Records containing: Stomach Neoplasms
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-09-30Phase I Trial of Intraperitoneal ²¹²Pb-TCMC-Trastuzumab for HER-2 Expressing Malignancy
-
CLINICAL_TRIALS study record update · 2016-09-13Impact of Widths After Gastric Tube Reconstruction on Quality of Life for Patients With Esophagogastric Cancers
-
CLINICAL_TRIALS study record update · 2016-08-23S-1 Plus Oxaliplatin Compared With Fluorouracil, Leucovorin Calcium Plus Oxaliplatin as Perioperative Chemotherapy for Advanced Gastric Carcinoma: a Multi-center, Open-labeled, Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2016-08-17Institut Paoli Calmettes Cardia Cancer Database
-
CLINICAL_TRIALS study record update · 2016-03-14A Phase II Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-02-23Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy
-
CLINICAL_TRIALS study record update · 2016-02-19The Randomized, Controlled, Multicenter Clinical Trial of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer
-
CLINICAL_TRIALS study record update · 2016-02-03Phase II Study of the Efficacy of no Antimicrobial Prophylaxis Use for Laparoscopic Distal Gastrectomy for Gastric Carcinoma
-
CLINICAL_TRIALS study record update · 2016-02-02Phase II Study Evaluating the Compliance to the Enhanced Recovery After Surgery (ERAS) Program in Patients Undergoing Gastrectomy for Gastric Carcinoma
-
CLINICAL_TRIALS study record update · 2016-01-26Serological Screening of Gastric Cancer in Wuxi Region
-
CLINICAL_TRIALS study record update · 2016-01-26A Phase II Study of Irinotecan as Single Agent in the Third Line Treatment of Unresectable or Metastatic Gastric Cancer.
-
CLINICAL_TRIALS study record update · 2015-08-26A Phase II, Open Label, Multiple Center Study of huC242-DM4 Given as an Intravenous Infusion Once Every Three Weeks to Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas
-
CLINICAL_TRIALS study record update · 2015-07-29The Expression of Zinc Finger E-Box Binding Homeobox 1 (ZEB1) in Circulating Tumor Cells(CTCs) Associated With Metastasis and Recurrence for Gastric Cancer
-
CLINICAL_TRIALS study record update · 2015-03-13A Phase 1 Study Of Sunitinib In Combination With S-1 And Cisplatin In Patients With Advanced Or Metastatic Gastric Cancer
-
CLINICAL_TRIALS study record update · 2015-03-10Omentectomy in Radical Gastrectomy for Gastric Cancer Trial
-
CLINICAL_TRIALS study record update · 2015-02-27Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal (GEJ) Tumors: A Phase II Study
-
CLINICAL_TRIALS study record update · 2015-02-25Cisplatin and S-1 With or Without Nimotuzumab for Patients With Previously Untreated Advanced Gastric Adenocarcinoma: a Single-center, Randomised, Open-label, Parallel-group, Controlled Phase 2 Clinical Trial
-
CLINICAL_TRIALS study record update · 2015-01-28A Phase ll Study of Oxaliplatin, Capecitabine, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas
-
CLINICAL_TRIALS study record update · 2015-01-27Multicenter Study on Comparison of Long-term Outcome Between Laparoscopic and Open Distal Subtotal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer
-
CLINICAL_TRIALS study record update · 2015-01-14Phase II Open Label Study to Evaluate the Biological Activity of ASLAN001 (ARRY 334543) in Patients With Recurrent/Metastatic Gastric, Gastro-oesophageal Junction, and Oesophageal Carcinoma Whose Tumours Are Epidermal Growth Factor Receptor-2 (HER 2) Amplified or Co-expressing Epidermal Growth Factor Receptor-1 (HER-1) and HER-2.
-
CLINICAL_TRIALS study record update · 2014-12-04a Phase II Study of Oxaliplatin Plus S-1 (SOX) as First-line Treatment for Patients With Advanced Gastric Cancer
-
CLINICAL_TRIALS study record update · 2014-12-02Prospective, Open, Multicentre Phase I/II Study to Evaluate the Safety and Efficacy of a Neoadjuvant Radiochemotherapy With Docetaxel and Oxalipaltin in Patients With Adenocarcinoma of the Gastric-oesophageal Junction
-
CLINICAL_TRIALS study record update · 2014-11-20A Phase II Trial of Intensity-Modulated Radiotherapy Combined With S-1 Based Chemotherapy in Completely Resected Gastric Cancer
-
CLINICAL_TRIALS study record update · 2014-11-04Docetaxel, Cisplatin and Fluorouracil Combination in the Neoadjuvant Treatment of Locally Advanced Gastric Adenocarcinoma : Phase II Clinical Study
-
CLINICAL_TRIALS study record update · 2014-09-26Acetic Acid Chromoendoscopy for Judging Extent of Gastric Intestinal Metaplasia